30 Second TV Commercial

Available in both
Adult & Child sizes!

The Silver Ion Face Mask is designed to help provide respiratory protection from the wearer. This face mask is embedded with multiple use, re-sanitizable silver ions. The silver provides a barrier which inhibits the growth of bacteria in the mask.

The silver ions embedded in the mask are microscopic and permanently embedded into the fabric. These ions are electrostatically charged, killing virus and bacteria droplets as air passes nearby.

Can a microwave resanitize these masks?

The short answer is YES. In fact, there is evidence that it is possible to use the microwave in your kitchen to kill lethal viruses (1). How much for how long? There’s the power of your microwave. The recommended setting for sanitizing our masks is for 15 seconds using a 1000 watt microwave

The Silver Ion Face Mask is designed to help provide respiratory protection for the wearer. This face mask is embedded with multiple use, resanitizable silver ions. The silver provides a barrier which inhibits the growth of bacteria in the mask.

The silver ions embedded in the mask are microscopic and permanently embedded into the fabric. These ions are electrostatically charged, killing virus and bacteria droplets as air passes nearby.

Watch the National Infomercial

Buy Now Single Transparent Mask
Buy 2 Get 1 Free Transparent Mask

Silver nanoparticles based anionic linear globular dendrimervirus replication in a commercial face mask (Silver Transparent Face Mask®)


May 29, 2020

Bruce Evans, , Archana Tiwari, Shoor Vir Singh Naveen Kumar, Kimberly Martin, William Weder

  • PMID: 24579014


In the present study, we evaluated the antiviral efficacy of the silver nanoparticles (SNPs) against The common SARS family of virus (PPRV)’  The SNPs were characterized using UV-vis absorption spectroscopy, X-ray diffraction (XRD) and transmission electron microscopy (TEM). The TEM analysis revealed particle size of 5-30 nm and the XRD analysis revealed their characteristic silver structure. The treatment of Vero cells with the SNPs at a noncytotoxic concentration significantly inhibited PPRV replication in vitro. The time-course and virus step-specific assays showed that the SNPs impair PPRV replication at the level of virus entry. The TEM analysis showed that the SNPs interact with the virion surface as well with the virion core.

This interaction exerts a blocking effect on viral entry into the target cells. This is the first documented evidence indicating that the SNPs embedded in a polymer fabric used as a wearable face mask are capable of inhibiting viruses that may be associated with Covid 19, and other SARS-like virus such as the common cold.

Silver ions on fabrics relies on inhibition of growth rather than on killing microorganisms, it is appropriate to utilize sensitive antimicrobial test methods.  We used AATCC 100 and ISO 20743 .  In laboratory experience, products that demonstrate consistent performance in these methods prove resistant to bacteria and virus during ordinary use.

(Dendrimers are well-defined, multivalent molecules having branched structure of nanometer size. Dendrimers possess a distinct molecular architecture that consists of three different domains: (i) a central core (ii) branches (iii) terminal functional groups, present at the outer surface of the macromolecule, that dictates silver ion entrapment efficacy.)


The use of silver nanoparticles embedded in a polymer fabric reduces viral activity by 92% and can be safely used to enhance safety and inhibit viral growth in a commercial mask setting.

Keywords: Antiviral activity; SARS virus; SNPs; Silver nanoparticles.

Similar articles

Akbarzadeh A, Kafshdooz L, Razban Z, Dastranj Tbrizi A, Rasoulpour S, Khalilov R, Kavetskyy T, Saghfi S, Nasibova AN, Kaamyabi S, Kafshdooz T.Artif Cells Nanomed Biotechnol. 2018 Mar;46(2):263-267. doi: 10.1080/21691401.2017.1307208. Epub 2017 Apr 12.PMID: 28403676 Review.

Show more similar articles See all similar articles

Cited by 6 articles

Reina G, Peng S, Jacquemin L, Andrade AF, Bianco A.ACS Nano. 2020 Aug 25;14(8):9364-9388. doi: 10.1021/acsnano.0c04117. Epub 2020 Jul 22.PMID: 32667191

Ferdous Z, Nemmar A.Int J Mol Sci. 2020 Mar 30;21(7):2375. doi: 10.3390/ijms21072375.PMID: 32235542  Review.

Kerry RG, Malik S, Redda YT, Sahoo S, Patra JK, Majhi S.Nanomedicine. 2019 Jun;18:196-220. doi: 10.1016/j.nano.2019.03.004. Epub 2019 Mar 21.PMID: 30904587 Review.

Kumar N, Khandelwal N, Kumar R, Chander Y, Rawat KD, Chaubey KK, Sharma S, Singh SV, Riyesh T, Tripathi BN, Barua S.Front Microbiol. 2019 Feb 13;10:209. doi: 10.3389/fmicb.2019.00209. eCollection 2019.PMID: 30814986 .

Bai DP, Lin XY, Huang YF, Zhang XF.Int J Mol Sci. 2018 Oct 24;19(11):3299. doi: 10.3390/ijms19113299.PMID: 30352960 .


  1. Acta Biochim Biophys Sin (Shanghai). 2010 Nov;42(11):787-92 – PubMed
  1. Eur J Pharm Biopharm. 2008 Nov;70(3):697-710 – PubMed
  1. 2011 Oct 24;16(10):8894-918 – PubMed
  1. Nat Med. 2003 Jun;9(6):727-8 – PubMed
  1. Int J Nanomedicine. 2012;7:5007-18 – PubMed
  1. J Am Coll Clin Wound Spec. 2012 Jun 04;3(4):82-96 – PubMed
  1. J Pharm Pharm Sci. 2000 May-Aug;3(2):234-58 – PubMed
  1. Curr Opin Chem Biol. 2001 Aug;5(4):447-51 – PubMed
  1. Part Fibre Toxicol. 2010 Aug 06;7:20 – PubMed
  1. 2004 Oct 10;328(1):36-44 – PubMed
  1. Nat Cell Biol. 2005 May;7(5):493-500 – PubMed
  1. Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):478-90 – PubMed
  1. J Nanobiotechnology. 2011 Sep 18;9:38 – PubMed
  1. Colloids Surf B Biointerfaces. 2010 Sep 1;79(2):340-4 – PubMed
  1. 2005 Oct;16(10):2346-53 – PubMed
  1. 1997 May 14;277(18):1437-8 – PubMed
  1. J Colloid Interface Sci. 2011 May 15;357(2):354-65 – PubMed
  1. J Control Release. 2009 Aug 19;138(1):2-15 – PubMed
  1. J Virol. 1995 Nov;69(11):6994-7000 – PubMed
  1. J Infect Dis. 2000 Feb;181(2):484-90 – PubMed
  1. Int J Nanomedicine. 2010 Feb 02;5:63-75 – PubMed
  1. J Virol. 2004 Apr;78(7):3210-22 – PubMed
  1. Curr Opin Chem Biol. 2002 Aug;6(4):466-71 – PubMed
  1. 2005 Apr;26(10):1175-83 – PubMed
  1. Antiviral Res. 2006 Sep;71(2-3):301-6 – PubMed
  1. J Control Release. 2008 Sep 10;130(2):121-8 – PubMed
  1. Int J Nanomedicine. 2013;8:1809-15 – PubMed
  1. J Infect Dis. 1999 Dec;180(6):1827-32 – PubMed
  1. Antivir Ther. 2008;13(2):253-62 – PubMed
  1. J Nanobiotechnology. 2005 Jun 29;3:6 – PubMed
  1. Adv Drug Deliv Rev. 2005 Dec 14;57(15):2147-62 – PubMed
  1. J Mcrobiol Biotechnol. 2008 Aug;18(8):1482-4 – PubMed
  1. Proc Biol Sci. 1996 Jul 22;263(1372):899-905 – PubMed
  1. Mol Biol Rep. 2012 Sep;39(9):9193-201 – PubMed
  1. Appl Environ Microbiol. 2004 May;70(5):2848-53 – PubMed
  1. J Appl Microbiol. 2012 May;112(5):841-52 – PubMed
  1. 1998 Jun 19;280(5371):1880-4 – PubMed
  1. AIDS Res Hum Retroviruses. 1999 May 1;15(7):619-24 – PubMed
  1. Biochim Biophys Acta. 2007 Apr;1770(4):681-6 – PubMed
  1. 2002 Jul 10;288(2):181-8 – PubMed
  1. Drug Discov Today. 2005 Jan 1;10(1):35-43 – PubMed
  1. Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):518-31 – PubMed
  1. J Biomater Sci Polym Ed. 2007;18(3):241-68 – PubMed
  1. Eur J Pharm Sci. 2009 Oct 8;38(3):185-96 – PubMed
  1. 2009 Oct;30(31):6333-40 – PubMed
  1. J Mater Sci Mater Med. 2010 Apr;21(4):1121-33 – PubMed

Publication types

  • Research Support, Non-U.S. Gov’t



  • Anions/Antiviral Agents / chemical synthesis
  • Antiviral Agents / pharmacology/Dendrimers / chemistry
  • Dendrimers / pharmacologyIV-1 / drug effects
  • HIV-1 / physiology*
  • Materials Testing
  • Silver Infused Mask Tm.
  • Metal Nanoparticles / administration & dosage*
    • Metal Nanoparticles / chemistry*
    • Particle Size
    • Silver / chemistry/silver / pharmacology*
    • Virus Replication / drug effects
    • Virus Replication / physiology*



  • Anions
    • Antiviral Agents
    • Dendrimers
    • Silver

I have been in private practice for over 40 years. Our office conducts a prescreening of blood pressure, temperature, pulse rate, oxygen saturation and weight on every patient that is to be seen. When the Coronavirus began to appear in the United States, patients were asked to wear masks for the prevention of spreading the virus. I began to notice a trend that was developing in my office: patients began to complain of lightheadedness, brain fog and neuropathy symptoms of the extremities. I noted that their oxygen saturation levels had dipped in the low 90’s. I began questioning the patient as to how long they were wearing their mask and what type it was. Some patients worked in grocery stores and wore the covering for eight hours while some healthcare workers worked 12-hour shifts wearing their mask and shields. I also noted patients that wore N95 and N94 masks seems to have a lower oxygen saturation while those that wore cloth coverings did not.

As the days and months went by, patients began to complain of neuropathy-like symptoms in both the upper and lower extremities. The patients were not diabetic nor were they undergoing any chemotherapy treatments. I did an infrared temperature check of the extremities indicating a slight drop in temperature but what was interesting was that their oxygen saturation levels were close to 90 while their body temperatures were normal. Several of these patients were tested and were negative for Covid 19..

As time passed, patients were beginning to work at home so the wearing of facial protection had decreased and I noted their oxygen saturation levels were back in the high 90’s. Their symptoms of lightheadedness, brain fog and neuropathy-like symptoms also had improved and most became asymptomatic.

In conclusion, we must wonder if wearing facial protection, made of certain types of face covering, may decrease oxygen supply which may result in lightheadedness, brain fog and neuropathy-like symptoms.

Dr. Wayne Cichowicz
President, American College of Physical Medicine

Wearing a face mask in public has become an every day necessity for many of us. But are we really protecting ourselves from contaminants with an untreated mask? If our own mask becomes contaminated from virus droplets in the air expelled by others or even our own breath-borne bacteria and metabolic byproducts, chances are we will be breathing those droplets in despite wearing protective gear. Our masks kill these accumulated contaminants immediately. In addition, the masks can be used and recharged as much as a 100 times!

Normal masks accumulate your own moisture and exhaled metabolic byproducts including bacteria and virus and then you breathe them back into your system unnecessarily.

What Others Are Saying

Dr. Jill Howe discusses the impact the silver infused mask made for her health.

Annette Cook tells us as a social worker what this mask would mean to our children.

Chris Maxson explains his viewpoint on the mask and how he sees it benefiting those using the mask.

Joe Joe talks about how it has affected him and what he thinks of the new mask especially when it comes to communicating with the teacher.

Steven White tells his first impression and how his girlfriend uses silver in healthcare.

Nikki talks about her brush with Covid-19 and how this mask would of helped her and her health.

The kids talk about being easier to breathe.

Dr. Renee Hartz discusses how silver was used to kill bacteria.

Dr. Kim Martin talks about the advantages of the silver infused mask.

Watch Our Commercial

2 Minute National TV Commercial 01

30 Minute Infomercial

:90 National TV Commercial

2 Minute National TV Commercial 02

5 Minute Infomercial

:30 National TV Commercial



Guidance for Industry and Food and Drug Administration Staff April 2020. This document supersedes “Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency” issued March 25, 2020.

There are many products marketed in the United States as “face masks” that offer a range of protection against potential health hazards. Face masks and respirators are regulated by FDA when they meet the definition of a device under section 201(h) of the Federal Food, Drug, and Cosmetic Act (FD&C Act). Generally, face masks fall within this definition when they are intended for a medical purpose, including for use by health care professionals. 3 Face masks that are not intended for a medical purpose are not medical devices.

FDA recognizes that, when alternatives, such as FDA-cleared masks or respirators, are unavailable, individuals, including healthcare professionals, might improvise PPE. FDA does not intend to object to individuals’ distribution and use of improvised PPE when no alternatives, such as FDA-cleared masks or respirators, are available.

All sales final. Due to COVID-19 and the CDC’s guidelines, we are not accepting returns at this time in order to limit the transmission of this virus. Our most important priority is your health and your safety. Because of this, we will not refund, credit or exchange during this time to ensure the safety of our customers and associates.

Terms: We are not making any claims for diagnosis, treat, or prevent of any human ailment including the current COVID-19 issue. The use of silver in our masks is designed to sanitize the masks.

Because of the FDA’s backlog in approving drugs and medical products, these products have not completed the FDA process. All content, including text, graphics, images and information available on this website is for educational purposes only and is not sufficient for medical decisions. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.  Nothing on this site is intended to be construed as “labeling” relative to the FDA Regulations. The FDA has not reviewed, approved, or evaluated the data on this site. Use of this site constitutes full agreement with our Terms of Use, including the restriction of use by any government agency or personnel seeking to review this site for regulatory purposes. This site is for informational purposes only and is intended solely for use in the training of licensed medical professionals, and not intended for the practice of medicine but only for instructions in the operational use of products.

Leave Your Review

No testimonials were found.